Abstract
Purpose
A newer formulation of bupivacaine, encapsulated within carrier molecules, has garnered attention for its role in providing extended post-operative analgesia. The purpose was to evaluate the addition of liposomal bupivacaine to fascia iliaca blockade during hip arthroscopy.
Methods
Retrospective cohort study of patients undergoing hip arthroscopy with a pre-operative fascia iliaca blockade with either liposomal bupivacaine (Group 1; 266mg + 20 cc 0.5% plain bupivacaine) or bupivacaine (Group 2; 40 cc 0.25% plain bupivacaine). All patients received standardized pre-operative oral pain medications. The primary outcome was the defense veteran pain rating scale (DVPRS). Secondary outcomes included duration of hospital admission, PACU opioid use, PACU pain scores, and duration of nerve blockade.
Results
Thirty-eight males and 30 females, mean age of 33 years (range 14–56). There was no difference in pre-operative DVPRS between the groups (n.s.). There was no difference in post-operative DVPRS pain scores at POD0 (3.7 vs. 3.9, n.s.), POD1 (4.2 vs. 3.8, n.s.), POD2 (4.2 vs. 3.7, n.s.), POD3 (3.9 vs. 3.7, n.s.) or POD14 (2.2 vs. 2.4, n.s.). Group 1 trended towards longer mean total hospital admission time (872 vs. 822 min, n.s.), and greater mean morphine equivalents administered in the PACU (33 vs. 29 mg, n.s.). 68% of patients in group 1 reported continued anterior thigh numbness at POD3, compared to 34% in group 2 (p = 0.008).
Conclusions
Despite the advertised benefits of prolonged post-operative analgesia using liposomal bupivacaine, there were no significant differences in post-operative pain scores or PACU opioid consumption. Our results support that acceptable pain scores are successfully achieved at all time periods with the use of multimodal analgesia including fascia iliaca blockade despite the type of pain medication administered.
Level of evidence
III.
Similar content being viewed by others
References
(1973) Evaluation of a local anesthetic agent. Bupivacaine hydrochloride (Marcaine). JAMA 224:1035–1036 (Editorial)
Abildgaard JT, Lonergan KT, Tolan SJ, Kissenberth MJ, Hawkins RJ, Washburn R 3rd et al. (2017) Liposomal bupivacaine versus indwelling interscalene nerve block for postoperative pain control in shoulder arthroplasty: a prospective randomized controlled trial. J Shoulder Elbow Surg 26:1175–1181
Alijanipour P, Tan TL, Matthews CN, Viola JR, Purtill JJ, Rothman RH et al (2017) Periarticular injection of liposomal bupivacaine offers no benefit over standard bupivacaine in total knee arthroplasty: a prospective, randomized, controlled trial. J Arthroplasty 32:628–634
Bozic KJ, Chan V, Valone FH 3rd, Feeley BT, Vail TP (2013) Trends in hip arthroscopy utilization in the United States. J Arthroplasty 28:140–143
Bramlett K, Onel E, Viscusi ER, Jones K (2012) A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee 19:530–536
Buckenmaier CC, 3rd, Galloway KT, Polomano RC, McDuffie M, Kwon N, Gallagher RM (2013) Preliminary validation of the defense and veterans pain rating scale (DVPRS) in a military population. Pain Med 14:110–123
Dalens B, Tanguy A, Vanneuville G (1989) Lumbar plexus blocks and lumbar plexus nerve blocks. Anesth Analg 69:852–854
Golf M, Daniels SE, Onel E (2011) A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 28:776–788
Gorfine SR, Onel E, Patou G, Krivokapic ZV (2011) Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 54:1552–1559
Hebbard P, Ivanusic J, Sha S (2011) Ultrasound-guided supra-inguinal fascia iliaca block: a cadaveric evaluation of a novel approach. Anaesthesia 66:300–305
Ilfeld BM, Malhotra N, Furnish TJ, Donohue MC, Madison SJ (2013) Liposomal bupivacaine as a single-injection peripheral nerve block: a dose–response study. Anesth Analg 117:1248–1256
Kay J, de Sa D, Memon M, Simunovic N, Paul J, Ayeni OR (2016) Examining the role of perioperative nerve blocks in hip arthroscopy: a systematic review. Arthroscopy 32:704–715 (e701)
Krych AJ, Baran S, Kuzma SA, Smith HM, Johnson RL, Levy BA (2014) Utility of multimodal analgesia with fascia iliaca blockade for acute pain management following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc 22:843–847
Kuang MJ, Du Y, Ma JX, He W, Fu L, Ma XL (2017) The efficacy of liposomal bupivacaine using periarticular injection in total knee arthroplasty: a systematic review and meta-analysis. J Arthroplasty 32:1395–1402
Kumar K, Pandey RK, Bhalla AP, Kashyap L, Garg R, Darlong V et al (2015) Comparison of conventional infrainguinal versus modified proximal suprainguinal approach of fascia iliaca compartment block for postoperative analgesia in total hip arthroplasty. A prospective randomized study. Acta Anaesthesiol Belg 66:95–100
Maradit Kremers H, Schilz SR, Van Houten HK, Herrin J, Koenig KM, Bozic KJ et al (2017) Trends in utilization and outcomes of hip arthroscopy in the United States between 2005 and 2013. J Arthroplasty 32:750–755
McGraw-Tatum MA, Groover MT, George NE, Urse JS, Heh V (2017) A prospective, randomized trial comparing liposomal bupivacaine vs fascia iliaca compartment block for postoperative pain control in total hip arthroplasty. J Arthroplasty 32:2181–2185
Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ (2017) Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. https://doi.org/10.1016/j.arth.2017.07.024
Nassif TH, Hull A, Holliday SB, Sullivan P, Sandbrink F (2015) Concurrent validity of the defense and veterans pain rating scale in VA outpatients. Pain Med 16:2152–2161
Okoroha KR, Keller RA, Marshall NE, Jung EK, Mehran N, Owashi E et al (2016) Liposomal bupivacaine versus femoral nerve block for pain control after anterior cruciate ligament reconstruction: a prospective randomized trial. Arthroscopy 32:1838–1845
Polomano RC, Galloway KT, Kent ML, Brandon-Edwards H, Kwon KN, Morales C et al (2016) Psychometric testing of the defense and veterans pain rating scale (DVPRS): a new pain scale for military population. Pain Med 17:1505–1519
Potter MQ, Sun GS, Fraser JA, Beckmann JT, Swenson JD, Maak TG et al (2014) Psychological distress in hip arthroscopy patients affects postoperative pain control. Arthroscopy 30:195–201
Richard BM, Newton P, Ott LR, Haan D, Brubaker AN, Cole PI et al. (2012) The safety of EXPAREL (R) (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogs. J Drug Deliv 2012:962101
Robbins J, Green CL, Parekh SG (2015) Liposomal bupivacaine in forefoot surgery. Foot Ankle Int 36:503–507
Viscusi ER, Sinatra R, Onel E, Ramamoorthy SL (2014) The safety of liposome bupivacaine, a novel local analgesic formulation. Clin J Pain 30:102–110
YaDeau JT, Tedore T, Goytizolo EA, Kim DH, Green DS, Westrick A et al (2012) Lumbar plexus blockade reduces pain after hip arthroscopy: a prospective randomized controlled trial. Anesth Analg 115:968–972
Funding
No source of funding.
Author information
Authors and Affiliations
Contributions
RP and DG were responsible for data collection and analysis. RP, KN and DG all participated in manuscript preparation and MM, TA, MK aided in final editing and proofs.
Corresponding author
Ethics declarations
Conflict of interest
Neither Richard Purcell, Kyle Nappo, Daniel Griffin, Michael McCabe, Terrence Anderson or Michael Kent have any financial disclosures or conflicts of interest to report.
Ethical approval
This study was appoved by our institution’s ethical review commitee in conjunction with the institutional review board approval.
Informed consent
For this type of study, formal consent was not required.
Additional information
The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of Army, Department of Defense, or US Government. Three authors are employees of the United States government. This work was prepared as part of their official duties and as such, there is no copyright to be transferred.
Rights and permissions
About this article
Cite this article
Purcell, R.L., Nappo, K.E., Griffin, D.W. et al. Fascia iliaca blockade with the addition of liposomal bupivacaine vs. plain bupivacaine for perioperative pain management following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc 26, 2536–2541 (2018). https://doi.org/10.1007/s00167-018-4874-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-018-4874-x